Asthma,PediatricAsthma,Dupilumab,AllergyTwitter,JACI

Mashup Score: 1

Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status - 5 day(s) ago

A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.

Source: www.hmpgloballearningnetwork.com

Categories: General Medicine News, Dermatology

Tweet Tweets with this article
- TheDermEditor
  
  New study: Dupilumab shows 2-year efficacy in kids (6–11 yrs) with type 2 asthma—regardless of allergy status. 🔹 Exacerbation rates ↓ in allergic & non-allergic subtypes 🔹 Serum IgE also reduced #Asthma #PediatricAsthma #Dupilumab #AllergyTwitter #JACI https://t.co/Xzk6BdXvrC